These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


207 related items for PubMed ID: 2160280

  • 1. Relationship of the multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase in the normal and in Fabry's disease.
    Beyer E, Schono N, Kozlova I, Wiederschain G.
    Biochim Biophys Acta; 1990 May 08; 1038(3):386-9. PubMed ID: 2160280
    [Abstract] [Full Text] [Related]

  • 2. [Substrate specificity of multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase].
    Baskaeva EM, Shono NI, Kozlova IK, Vidershaĭn GIa.
    Biokhimiia; 1989 Mar 08; 54(3):421-6. PubMed ID: 2546612
    [Abstract] [Full Text] [Related]

  • 3. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease.
    Mayes JS, Scheerer JB, Sifers RN, Donaldson ML.
    Clin Chim Acta; 1981 May 05; 112(2):247-51. PubMed ID: 6263521
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes.
    Fensom AH, Benson PF, Grant AR, Jacobs L.
    J Inherit Metab Dis; 1980 May 05; 2(1):9-12. PubMed ID: 6273649
    [Abstract] [Full Text] [Related]

  • 5. [Alpha-galactosidases and alpha-N-acetylgalactosaminidase. Biochemical bases of Fabry's disease].
    Salvayre R, Negre A, Maret A, Douste-Blazy L.
    Pathol Biol (Paris); 1984 Apr 05; 32(4):269-84. PubMed ID: 6326022
    [Abstract] [Full Text] [Related]

  • 6. [Biochemical studies in Fabry's disease (author's transl)].
    Handa S.
    Nihon Jinzo Gakkai Shi; 1978 Nov 05; 20(11):1212-4. PubMed ID: 219278
    [No Abstract] [Full Text] [Related]

  • 7. Molecular pathology of Fabry's disease. Physical and kinetic properties of alpha-galactosidase A in cultured human endothelial cells.
    Johnson DL, Desnick RJ.
    Biochim Biophys Acta; 1978 Jan 18; 538(2):195-204. PubMed ID: 23178
    [No Abstract] [Full Text] [Related]

  • 8. Amiodarone phenocopy of Fabry's keratopathy.
    Whitley CB, Tsai MY, Heger JJ, Prystowsky EN, Zipes DP.
    JAMA; 1978 Jan 18; 249(16):2177-8. PubMed ID: 6300478
    [No Abstract] [Full Text] [Related]

  • 9. Properties of immobilized fig alpha-galactosidase and effect on ceramide-3 content of plasma from patients with Fabry's disease.
    Schram AW, Hamers MN, Oldenbroek-Haverkamp E, Strijland A, de Jonge A, van den Bergh FA, Tager JM.
    Biochim Biophys Acta; 1978 Dec 08; 527(2):456-64. PubMed ID: 31916
    [Abstract] [Full Text] [Related]

  • 10. Loss of electron-dense lamellar material from Fabry's disease fibroblasts after enzyme replacement.
    Sifers RN, Mayes JS, Nordquist RE.
    Hum Genet; 1983 Dec 08; 65(1):85-7. PubMed ID: 6315565
    [Abstract] [Full Text] [Related]

  • 11. The fate of internalized alpha-2-macroglobulin: alpha-galactosidase conjugate in fibroblasts from Fabry's hemizygote.
    Osada T, Kuroda Y, Ikai A.
    Biochem Biophys Res Commun; 1987 Mar 30; 143(3):954-8. PubMed ID: 2436620
    [Abstract] [Full Text] [Related]

  • 12. Residual activity of alpha-galactosidase A in Fabry's disease.
    Romeo G, D'Urso M, Pisacane A, Blum E, De Falco A, Ruffilli A.
    Biochem Genet; 1975 Oct 30; 13(9-10):615-28. PubMed ID: 812485
    [Abstract] [Full Text] [Related]

  • 13. beta-Fucosidase, beta-glucosidase and beta-galactosidase activities associated in bovine liver.
    Rodriguez JA, Cabezas JA, Calvo P.
    Int J Biochem; 1982 Oct 30; 14(8):695-8. PubMed ID: 6811346
    [Abstract] [Full Text] [Related]

  • 14. Fabry's disease: biochemical and histochemical studies on hair roots for carrier detection.
    Vermorken AJ, Weterings PJ, Spierenburg GT, vanBennekom CA, Wirtz P, deBruyn CH, Oei TL.
    Br J Dermatol; 1978 Feb 30; 98(2):191-6. PubMed ID: 204324
    [Abstract] [Full Text] [Related]

  • 15. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients.
    Tanaka M, Ohashi T, Kobayashi M, Eto Y, Miyamura N, Nishida K, Araki E, Itoh K, Matsushita K, Hara M, Kuwahara K, Nakano T, Yasumoto N, Nonoguchi H, Tomita K.
    Clin Nephrol; 2005 Oct 30; 64(4):281-7. PubMed ID: 16240899
    [Abstract] [Full Text] [Related]

  • 16. Properties of multiple molecular forms of alpha-galactosidase and alpha-N-acetylgalactosaminidase from normal and Fabry leukocytes.
    Salvayre R, Maret A, Negre A, Douste-Blazy L.
    Eur J Biochem; 1979 Oct 15; 100(2):377-83. PubMed ID: 41709
    [No Abstract] [Full Text] [Related]

  • 17. Genetic relationship between beta-galactosidase and beta-fucosidase in the mouse.
    Seyedyazdani R, Lundin LG.
    Biochem Genet; 1974 Dec 15; 12(6):441-8. PubMed ID: 4458657
    [No Abstract] [Full Text] [Related]

  • 18. The properties of alpha-galactosidase remaining in kidney and liver of patients with Fabry's disease.
    Kano I, Yamakawa T.
    Chem Phys Lipids; 1974 Dec 15; 13(4):283-91. PubMed ID: 4217662
    [No Abstract] [Full Text] [Related]

  • 19. Cardiopulmonary involvement in Fabry's disease.
    Koskenvuo JW, Kantola IM, Nuutila P, Knuuti J, Parkkola R, Mononen I, Hurme S, Kalliokoski R, Viikari JS, Wendelin-Saarenhovi M, Kiviniemi TO, Hartiala JJ.
    Acta Cardiol; 2010 Apr 15; 65(2):185-92. PubMed ID: 20458826
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.